Cargando…

Associations of tumor suppressor SPARCL1 with cancer progression and prognosis

SPARC-like protein 1 (SPARCL1), a member of the family of secreted proteins which is acidic and rich in cysteine, is a potential tumor suppressor gene in most types of tumor. A systemic review and bioinformatics analysis was carried out to determine the associations between SPARCL1 and tumor progres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ting, Liu, Xia, Yang, Antai, Fu, Wenjie, Yin, Fuqiang, Zeng, Xiaoyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588123/ https://www.ncbi.nlm.nih.gov/pubmed/28927026 http://dx.doi.org/10.3892/ol.2017.6546

Ejemplares similares

Sparcl1 and Atherosclerosis
por: Cheng, Xu, et al.
Publicado: (2023)

Disadvantages of a SPARCling defense
por: Bashyam, Hema
Publicado: (2008)

Prognostic value of SPARCL1 in patients with colorectal cancer
por: Han, Wei, et al.
Publicado: (2018)

SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer
por: Zhang, Hai-Ping, et al.
Publicado: (2022)

Effects of SPARCL1 on the proliferation and differentiation of sheep preadipocytes
por: Xiao, Cheng, et al.
Publicado: (2021)

Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma
por: Yin, Fuqiang, et al.
Publicado: (2016)

Sparcle: assigning transcripts to cells in multiplexed images
por: Prabhakaran, Sandhya
Publicado: (2022)

Immunological role and prognostic value of SPARCL1 in pan-cancer analysis
por: He, Kangwei, et al.
Publicado: (2022)

Atorvastatin in stroke: a review of SPARCL and subgroup analysis
por: Huisa, Branko N, et al.
Publicado: (2010)

Mutations in Hevin/Sparcl1 and risk of autism spectrum disorder
por: Taketomi, Takumi, et al.
Publicado: (2022)

CDD/SPARCLE: functional classification of proteins via subfamily domain architectures
por: Marchler-Bauer, Aron, et al.
Publicado: (2017)

Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation
por: Deng, Huan, et al.
Publicado: (2021)

Methylation of SPARCL1 Is Associated with Oncologic Outcome of Advanced Upper Urinary Tract Urothelial Carcinoma
por: Luo, Hao-Lun, et al.
Publicado: (2019)

Autism-associated mutation in Hevin/Sparcl1 induces endoplasmic reticulum stress through structural instability
por: Taketomi, Takumi, et al.
Publicado: (2022)

Species-, organ- and cell-type-dependent expression of SPARCL1 in human and mouse tissues
por: Klingler, Anika, et al.
Publicado: (2020)

Matricellular Protein SPARCL1 Regulates Blood Vessel Integrity and Antagonizes Inflammatory Bowel Disease
por: Regensburger, Daniela, et al.
Publicado: (2021)

Quality of Life in Young Adults With Cerebral Palsy: A Longitudinal Analysis of the SPARCLE Study
por: Vidart d'Egurbide Bagazgoïtia, Nicolas, et al.
Publicado: (2021)

Identifying liver metastasis-related hub genes in breast cancer and characterizing SPARCL1 as a potential prognostic biomarker
por: Chen, Mingkuan, et al.
Publicado: (2023)

Hevin/Sparcl1 drives pathological pain through spinal cord astrocyte and NMDA receptor signaling
por: Chen, Gang, et al.
Publicado: (2022)

Study protocol: Determinants of participation and quality of life of adolescents with cerebral palsy: a longitudinal study (SPARCLE2)
por: Colver, Allan F, et al.
Publicado: (2010)

TCEAL2 as a Tumor Suppressor in Renal Cell Carcinoma is Associated with the Good Prognosis of Patients
por: Zhou, Yingchen, et al.
Publicado: (2020)

Complement component 7 (C7), a potential tumor suppressor, is correlated with tumor progression and prognosis
por: Ying, Lisha, et al.
Publicado: (2016)

SPARCL1 Influences Bovine Skeletal Muscle-Derived Satellite Cell Migration and Differentiation through an ITGB1-Mediated Signaling Pathway
por: Wang, Yuxin, et al.
Publicado: (2020)

Study protocol: SPARCLE – a multi-centre European study of the relationship of environment to participation and quality of life in children with cerebral palsy
por: Colver, Allan
Publicado: (2006)

Association of Major Adverse Cardiac Events and Beta-Blockers in Patients with and without Atherosclerotic Cardiovascular Disease: Long-Term Follow-Up Results of the T-SPARCLE and T-PPARCLE Registry in Taiwan
por: Liu, Patrick Yan-Tyng, et al.
Publicado: (2023)

Mitochondrial Tumor Suppressors—The Energetic Enemies of Tumor Progression
por: Jakoube, Pavel, et al.
Publicado: (2021)

SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT–receptor complex
por: Zhao, S-J, et al.
Publicado: (2018)

Determinants of participation and quality of life of young adults with cerebral palsy: longitudinal approach and comparison with the general population – SPARCLE 3 study protocol
por: Arnaud, Catherine, et al.
Publicado: (2021)

Bioinformatics analysis and identification of upregulated tumor suppressor genes associated with suppressing colon cancer progression by curcumin treatment
por: Wu, Dan, et al.
Publicado: (2023)

Research Progress of TXNIP as a Tumor Suppressor Gene Participating in the Metabolic Reprogramming and Oxidative Stress of Cancer Cells in Various Cancers
por: Chen, Yiting, et al.
Publicado: (2020)

Potential Tumor Suppressor NESG1 as an Unfavorable Prognosis Factor in Nasopharyngeal Carcinoma
por: Liu, Zhen, et al.
Publicado: (2011)

SPARCL1 promotes C2C12 cell differentiation via BMP7-mediated BMP/TGF-β cell signaling pathway
por: Wang, YuXin, et al.
Publicado: (2019)

The association between KLF4 as a tumor suppressor and the prognosis of hepatocellular carcinoma after curative resection
por: Xue, Min, et al.
Publicado: (2020)

Recent progress in the study of methylated tumor suppressor genes in gastric cancer
por: Hu, Xiao-Tong, et al.
Publicado: (2013)

Circular_0086414 induces SPARC like 1 (SPARCL1) production to inhibit esophageal cancer cell proliferation, invasion and glycolysis and induce cell apoptosis by sponging miR-1290
por: Jiang, Qingfeng, et al.
Publicado: (2022)

Retinoblastoma tumor suppressor pathway in breast cancer: prognosis, precision medicine, and therapeutic interventions
por: Witkiewicz, Agnieszka K, et al.
Publicado: (2014)

Hypermethylation of DHRS3 as a Novel Tumor Suppressor Involved in Tumor Growth and Prognosis in Gastric Cancer
por: Sumei, Sha, et al.
Publicado: (2021)

SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
por: Deng, Chu-Xia
Publicado: (2009)

Myeloid-Derived Suppressor Cells: A New and Pivotal Player in Colorectal Cancer Progression
por: Yin, Kai, et al.
Publicado: (2020)

Tumor suppressor death-associated protein kinase 1 inhibits necroptosis by p38 MAPK activation
por: Wu, Yung-Hsuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jhjumdmr5an3sf08sk2hlu51rf